Pharmaceutical tablet

- Glaxo Group Limited
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front perspective view of a pharmaceutical tablet showing our new design;

FIG. 2 is a top view thereof;

FIG. 3 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 4 is a bottom view thereof;

FIG. 5 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 6 is a cross-sectional view through section 66 of FIG. 1;

FIG. 7 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 8 is a top view thereof;

FIG. 9 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 10 is a bottom view thereof;

FIG. 11 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 12 is a cross-sectional view through section 1212 of FIG. 7;

FIG. 13 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 14 is a top view thereof;

FIG. 15 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 16 is a bottom view thereof;

FIG. 17 is a front view thereof, with the rear view thereof being identical thereto;

FIG. 18 is a cross-sectional view through section 1818 of FIG. 13;

FIG. 19 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 20 is a top view thereof;

FIG. 21 is a right side view thereof, with the left side view thereof being identical thereto;

FIG. 22 is a bottom view thereof;

FIG. 23 is a front view thereof, with the rear view thereof being identical thereto; and,

FIG. 24 is a cross-sectional view through section 2424 of FIG. 19.

The grayscale shading in FIGS. 19–24 depict a color contrast, and is not indicative of any specific color.

Claims

The ornamental design for a pharmaceutical tablet, as shown and described.

Referenced Cited
U.S. Patent Documents
1419618 June 1922 Deming
1580576 April 1926 Edmund
2102885 December 1937 Carroll
2340037 January 1944 Irving
3048526 August 1962 Boswell
3620759 November 1971 Maddox
3702653 November 1972 Motten
D235215 May 1975 Larson
D258091 January 27, 1981 Reed et al.
4376111 March 8, 1983 Tovey
D269718 July 12, 1983 Tovey
D269721 July 12, 1983 Tovey
D269722 July 12, 1983 Tovey
D274846 July 24, 1984 Eoga
D283649 April 29, 1986 Casberg
4601896 July 22, 1986 Nugent
D285363 August 26, 1986 Tovey
D286085 October 7, 1986 Tovey
4643731 February 17, 1987 Eckenhoff
4735805 April 5, 1988 Ni et al.
4883182 November 28, 1989 Hughes
D376643 December 17, 1996 Hatton et al.
D420464 February 8, 2000 Binstock et al.
D506545 June 21, 2005 McAllister et al.
D520635 May 9, 2006 Bonny et al.
D530814 October 24, 2006 Bonny et al.
D535741 January 23, 2007 Stawski et al.
7214396 May 8, 2007 Rivier
D556946 December 4, 2007 Seum et al.
D561992 February 19, 2008 Linsley
D564086 March 11, 2008 Nielsen et al.
D576776 September 16, 2008 Klacik et al.
Other references
  • Karolak et al., U.S. Appl. No. 29/268,559, filed Nov. 9, 2006.
Patent History
Patent number: D610674
Type: Grant
Filed: Aug 28, 2008
Date of Patent: Feb 23, 2010
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Wlodek Karolak (Mississauga), Helen Anne Willy (Harlow)
Primary Examiner: Charles A Rademaker
Assistant Examiner: Charles D Hanson
Attorney: Nixon & Vanderhye P.C.
Application Number: 29/309,538
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)